News
Sarepta Therapeutics hired a Trump-connected lobbying firm after the death of a teenage boy treated with its Duchenne ...
Asianet Newsable on MSN25m
Novartis Reportedly Eyeing To Acquire Avidity Biosciences: But Retail Expects Management To Sell Only At Significant PremiumNovartis has been evaluating a bid for Avidity and expressed interest in an acquisition in recent weeks, FT reported.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback